|
The Journal of Lipid Research, Vol. 39, 1008-1020, May 1998
Copyright © 1998 by Lipid Research, Inc.
Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL
Stewart C. Whitmana,
Cynthia G. Sawyeza,
David B. Millera,
Bernard M. Wolfea, and
Murray W. Huffa
a Departments of Medicine and Biochemistry, and the Robarts Research Institute at The University of Western Ontario, 100 Perth Drive, London, Ontario, Canada N6A 5K8
Correspondence to:
Murray W. Huff.
We have previously shown that very low density lipoproteins (VLDL, Sf 60400) from subjects with type IV hyperlipoproteinemia (HTG-VLDL) will induce appreciable cholesteryl ester accumulation in cultured macrophages (J774A.1). The present study examined whether copper- mediated oxidative modification of HTG-VLDL and their remnants would further enhance cholesteryl ester accumulation in J774A.1 cells. Incubation with oxidized VLDL-remnants caused the greatest increase in cellular cholesteryl ester concentrations (54-fold) relative to control cells (P = 0.001). HTG-VLDL and VLDL-remnants each induced similar increases in cholesteryl ester levels (32.3- and 35.8-fold, respectively; both P = 0.001), whereas incubation with oxidized HTG-VLDL brought about only a 20.6-fold increase in cholesteryl ester concentrations (P = 0.014). The increase in cellular cholesteryl ester concentrations induced by oxidized VLDL-remnants was significantly higher (P 0.04) than that induced by all other lipoproteins tested including low density lipoprotein (LDL) and oxidized LDL which caused a 6.7- and a 35.1-fold increase (P 0.0002 for both), respectively. Unlike HTG-VLDL and to a lesser extent VLDL-remnants, uptake of oxidized VLDL and oxidized VLDL-remnants did not require catalytically active, cell secreted lipoprotein lipase. Co-incubation with polyinosine, which blocks binding to the type I scavenger receptor, completely inhibited the cholesteryl ester accumulation induced by oxidized HTG-VLDL, oxidized VLDL-remnants and oxidized LDL (P 0.02).
We conclude that oxidation of VLDL-remnants significantly enhances macrophage cholesteryl ester accumulation compared to either HTG-VLDL, VLDL-remnants, or oxidized LDL. Uptake of oxidized VLDL and oxidized VLDL-remnants does not require catalytically active lipoprotein lipase, and involves a receptor that can be competed for by polyinosine.Whitman, S. C., C. G. Sawyez, D. B. Miller, B. M. Wolfe, and M. W. Huff. Oxidized Type IV Hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. J. Lipid Res. 1998. 39: 10081020.
Supplementary key words:
type IV hyperlipoproteinemia, VLDL-remnants, oxidation, foam cells, scavenger receptor, lipoprotein lipase, macrophages

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Argmann, J. Y. Edwards, C. G. Sawyez, C. H. O'Neil, R. A. Hegele, J. G. Pickering, and M. W. Huff
Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition: A ROLE FOR RhoA IN ABCA1-MEDIATED CHOLESTEROL EFFLUX
J. Biol. Chem.,
June 10, 2005;
280(23):
22212 - 22221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Halvorsen, T. Waehre, H. Scholz, O. P. Clausen, J. H. von der Thusen, F. Muller, H. Heimli, S. Tonstad, C. Hall, S. S. Froland, et al.
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
J. Lipid Res.,
February 1, 2005;
46(2):
211 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Argmann, C. G. Sawyez, S. Li, Z. Nong, R. A. Hegele, J. G. Pickering, and M. W. Huff
Human Smooth Muscle Cell Subpopulations Differentially Accumulate Cholesteryl Ester When Exposed to Native and Oxidized Lipoproteins
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2004;
24(7):
1290 - 1296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Kaysen and J. P. Eiserich
The Role of Oxidative Stress-Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
J. Am. Soc. Nephrol.,
March 1, 2004;
15(3):
538 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Rowe, C. A. Argmann, J. Y. Edwards, C. G. Sawyez, O. H. Morand, R. A. Hegele, and M. W. Huff
Enhanced Synthesis of the Oxysterol 24(S),25-Epoxycholesterol in Macrophages by Inhibitors of 2,3-Oxidosqualene:Lanosterol Cyclase: A Novel Mechanism for the Attenuation of Foam Cell Formation
Circ. Res.,
October 17, 2003;
93(8):
717 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.D. Norata, A. Pirillo, E. Callegari, A. Hamsten, A.L. Catapano, and P. Eriksson
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL
Cardiovasc Res,
July 1, 2003;
59(1):
169 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Argmann, C. H. Van Den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Hegele, B. M. Wolfe, and M. W. Huff
Transforming Growth Factor-{beta}1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2001;
21(12):
2011 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Jong, W. L. Hendriks, L. C. van Vark, V. E. H. Dahlmans, J. E. M. Groener, and L. M. Havekes
Oxidized VLDL Induces Less Triglyceride Accumulation in J774 Macrophages Than Native VLDL Due to an Impaired Extracellular Lipolysis
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2000;
20(1):
144 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Cohn, C. Marcoux, and J. Davignon
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1999;
19(10):
2474 - 2486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Whitman, C. A. Argmann, C. G. Sawyez, D. B. Miller, R. A. Hegele, and M. W. Huff
Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-{gamma}
J. Lipid Res.,
June 1, 1999;
40(6):
1017 - 1028.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. J. Wilcox, P. H. R. Barrett, and M. W. Huff
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
J. Lipid Res.,
June 1, 1999;
40(6):
1078 - 1089.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. C. Whitman, S. L. Hazen, D. B. Miller, R. A. Hegele, J. W. Heinecke, and M. W. Huff
Modification of Type III VLDL, Their Remnants, and VLDL From ApoE-Knockout Mice by p-Hydroxyphenylacetaldehyde, a Product of Myeloperoxidase Activity, Causes Marked Cholesteryl Ester Accumulation in Macrophages
Arterioscler. Thromb. Vasc. Biol.,
May 1, 1999;
19(5):
1238 - 1249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Wilcox, P. H. R. Barrett, R. S. Newton, and M. W. Huff
ApoB100 Secretion From HepG2 Cells is Decreased by the ACAT Inhibitor CI-1011 : An Effect Associated With Enhanced Intracellular Degradation of ApoB
Arterioscler. Thromb. Vasc. Biol.,
April 1, 1999;
19(4):
939 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. R. Babaev, M. B. Patel, C. F. Semenkovich, S. Fazio, and M. F. Linton
Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient Mice
J. Biol. Chem.,
August 18, 2000;
275(34):
26293 - 26299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ahmed, A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. L. Du, A. Kuksis, and P. W. Connelly
Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor
J. Biol. Chem.,
June 29, 2001;
276(27):
24473 - 24481.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|